MSR1 and ovarian cancer: While previously it was shown that lack of MSR1 delayed the growth of EL4 lymphoma in mice by increased pro‐inflammatory responses to necrotic cells (Komohara et al, 2009), our data revealed an increased expression of K63‐polyubiquitylated MSR1 in a human ovarian cancer.